Restless legs syndrome in patients after renal transplantation

被引:89
作者
Molnar, MZ
Novak, M
Ambrus, C
Szeifert, L
Kovacs, A
Pap, J
Remport, A
Mucsi, I
机构
[1] Semmelweis Univ, Inst Behav Sci, Dept Internal Med 1, Budapest, Hungary
[2] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[3] Hungarian Acad Sci, Budapest, Hungary
[4] Semmelweis Univ, Nephrol Res Grp, Budapest, Hungary
[5] Semmelweis Univ, Fresenius Med Care Dialysis Ctr, Budapest, Hungary
[6] Univ Toronto, Dept Psychiat, Sleep Res Lab, Toronto, ON, Canada
基金
匈牙利科学研究基金会;
关键词
restless legs syndrome; chronic kidney disease; dialysis; kidney transplantation; end-stage renal disease (ESRD);
D O I
10.1053/j.ajkd.2004.10.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: There is an almost complete lack of information on the epidemiology of sleep disorders in kidney-transplanted patients. In this report the authors assess the prevalence and clinical correlates of restless legs syndrome (RLS) in kidney-transplanted (Tx) patients. They also analyze the impact of declining renal function on this condition in the Tx population. Finally, the prevalence of RLS was compared between waitlisted dialysis patients (WL), and the Tx group. Methods: In a cross-sectional study enrolling 992 patients (816 Tx and 176 WL), the presence of RLS was assessed using the Restless Legs Syndrome Questionnaire. Clinical and sociodemographic data were collected from the patients' medical records. Results: In transplanted patients, the prevalence of RLS was 4.8%. RLS was associated strongly with declining renal function. In groups formed on the basis of estimated glomerular filtration rate (eGFR), the prevalence of RLS was 1.8%, 5.1%a, 6.5%, and 23.5% in patients with eGFR greater than 60 mL/min/1.73 m(2); eGFR 30 to 59 mL/min/1.73 m(2); eGFR 15 to 29 mL/min/1.73 m(2); and eGFR less than 15 mL/min/1.73 m(2), respectively (P < 0.001). There was also a significant association between RLS and lower serum hemoglobin, higher number of self-reported comorbid conditions, and higher prevalence of iron deficiency. RLS was significantly less frequent in patients taking steroids than in patients not taking this medication (4% versus 9%, P < 0.05). In multivariate analysis, not taking steroids, eGFR, self-reported comorbidity, and iron deficiency were significant and independent predictors of RLS. Dialysis treatment was associated with increased odds for RLS (odds ratio 2.2; 95% confidence interval 1.11 to 4.35; P < 0.05) even after adjusting for serum hemoglobin and comorbidity. Conclusion: The prevalence of RLS is significantly lower in Tx patients than in patients on maintenance dialysis. Declining renal function is associated with increasing prevalence of the condition.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 34 条
[1]   Dopamine and iron in the pathophysiology of restless legs syndrome (RLS) [J].
Allen, R .
SLEEP MEDICINE, 2004, 5 (04) :385-391
[2]   Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health [J].
Allen, RP ;
Picchietti, D ;
Hening, WA ;
Trenkwalder, C ;
Walters, AS ;
Montplaisi, J .
SLEEP MEDICINE, 2003, 4 (02) :101-119
[3]   Restless legs syndrome - A review of clinical and pathophysiologic features [J].
Allen, RP ;
Earley, CJ .
JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2001, 18 (02) :128-147
[4]  
Allen RP, 2001, NEUROLOGY, V56, pA4
[5]   A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study) [J].
Benz, RL ;
Pressman, MR ;
Hovick, ET ;
Peterson, DD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :1089-1095
[6]   Sex and the risk of restless legs syndrome in the general population [J].
Berger, K ;
Luedemann, J ;
Trenkwalder, C ;
Ulrich, J ;
Kessler, C .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) :196-202
[7]   Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis [J].
Cirignotta, F ;
Mondini, S ;
Santoro, A ;
Ferrari, G ;
Gerardi, R ;
Buzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :302-306
[8]   Clinical and biochemical findings in uremic patients with and without restless legs syndrome [J].
Collado-Seidel, V ;
Kohnen, R ;
Samtleben, W ;
Hillebrand, GF ;
Oertel, WH ;
Trenkwalder, C .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) :324-328
[9]   The treatment of restless legs syndrome with intravenous iron dextran [J].
Earley, CJ ;
Heckler, D ;
Allen, RP .
SLEEP MEDICINE, 2004, 5 (03) :231-235
[10]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266